One of the primary challenges is the ubiquitous nature of NF-κB and its role in maintaining normal cellular functions. Non-specific inhibition can lead to unwanted side effects, including immunosuppression and increased susceptibility to infections. Another challenge is the redundancy and complexity of the NF-κB signaling network, which can activate compensatory pathways that undermine the efficacy of targeted therapies.
